Related Experiment Video
Updated: Nov 8, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
A 33-year follow-up after valvular surgery for carcinoid heart disease
Johannes Bergsten1,2, Frank A Flachskampf1,2, Lennart Lundin1,2
1Department of Clinical Physiology and Cardiology, University Hospital, Uppsala, Sweden.
Insights
Valvular surgery for carcinoid heart disease (CaHD) improves survival, especially with combined tricuspid and pulmonary valve replacement. Biomarkers like NT-pro-BNP and 5-HIAA predict poor outcomes in CaHD patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Oncology
Background:
- Carcinoid heart disease (CaHD) involves valvular damage, primarily affecting the tricuspid and pulmonary valves.
- Surgical intervention for severe CaHD has improved long-term prognosis, but data on survival predictors and optimal surgical strategy remain limited.
Purpose of the Study:
- To review survival and echocardiographic findings in patients who underwent valvular surgery for severe CaHD.
- To identify predictors of survival and evaluate the strategy of single versus double-valve surgery in CaHD.
Main Methods:
- Retrospective review of 60 consecutive patients with severe CaHD undergoing valve surgery between 1986 and 2019.
- Analysis included preoperative echocardiography, creatinine, NT-pro-brain natriuretic peptide (NT-pro-BNP), and 24-h urinary 5-hydroxyindoleacetic acid (5-HIAA).
- Surgical procedures were categorized into combined tricuspid valve replacement (TVR) and pulmonary valve replacement (PVR) versus TVR-only or TVR with pulmonary valvotomy.
Main Results:
- 30-day mortality was 12%, decreasing to 8% in the most recent decade (2010-2019). Median survival was 2.2 years.
- Combined TVR and PVR demonstrated significantly higher survival rates (median 3.0 years) compared to operations without PVR (median 0.9 years).
- Elevated preoperative NT-pro-BNP and 5-HIAA levels in the top quartile were associated with poor survival. Preoperative echocardiography sometimes underestimated pulmonary valve pathology.
Conclusions:
- Valvular surgery for CaHD is associated with acceptable perioperative risk.
- Combined TVR and PVR should be considered for most CaHD patients due to improved survival outcomes.
- Bioprosthetic valves show adequate durability relative to the oncological life expectancy of CaHD patients.
Aims:
Valvular surgery has improved long-term prognosis in severe carcinoid heart disease (CaHD). Experience is limited and uncertainty remains about predictors for survival and strategy regarding single vs. double-valve surgery. The aim was to review survival and echocardiographic findings after valvular surgery for CaHD at our institution.
Methods And Results:
Between 1986 and 2019, 60 consecutive patients, median age 64 years, underwent valve surgery for severe CaHD. Operations involved combined tricuspid valve replacement (TVR) and pulmonary valve replacement (PVR) in 42 cases, and TVR-only or TVR with pulmonary valvotomy (no PVR) in 18 patients. All implanted valves were bioprosthetic. Preoperative echocardiography, creatinine, NT-pro-brain natriuretic peptide (NT-pro-BNP), and 24-h urinary 5-hydroxyindoleacetic acid (5-HIAA) were obtained. 30-Day mortality was 12% (n=7), and 8% for the most recent decade 2010-2019. Median survival was 2.2 years and maximum survival 21 years. Patients undergoing combined TVR and PVR had significantly higher survival compared with operations without PVR (median 3.0 vs. 0.9 years, P = 0.02). Preoperative levels of NT-pro-BNP and 5-HIAA in the top quartile predicted poor survival. On preoperative echocardiograms, pulmonary regurgitation was severe in 51% and indeterminate in 17%. Postoperative echocardiography confirmed relatively good durability of bioprostheses, relative to the patients' limited oncological life expectancy.
Conclusion:
Valvular surgery in CaHD has an acceptable perioperative risk. Survival for combined TVR and PVR was significantly higher compared with operations without PVR. Bioprosthetic valve replacement appears to have adequate durability. Preoperative echocardiography may underestimate pulmonary pathology. Combined TVR and PVR should be considered in most patients.
More Related Videos
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Mitral Stenosis IV: Nursing Management